Cargando…
Challenges for Plasma-Derived Medicinal Products
BACKGROUND: Plasma-derived medicinal products (PDMPs) are medicinal products derived from human plasma, and a number of PDMPs are listed on the WHO Model List of Essential Medicines. These and other PDMPs are crucial for the prophylaxis and treatment of patients with immune deficiencies, autoimmune...
Autor principal: | Strengers, Paul F.W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091012/ https://www.ncbi.nlm.nih.gov/pubmed/37066053 http://dx.doi.org/10.1159/000528959 |
Ejemplares similares
-
Prothrombin complex concentrate versus fresh frozen plasma in patients on oral anticoagulant therapy undergoing cardiac surgery: a randomized study
por: Demeyere, R, et al.
Publicado: (2006) -
Specific protein content of pools of plasma for fractionation from different sources: impact of frequency of donations
por: Laub, R, et al.
Publicado: (2010) -
The effect of C1-esterase inhibitor on systemic inflammation in trauma patients with a femur fracture - The CAESAR study: study protocol for a randomized controlled trial
por: Heeres, Marjolein, et al.
Publicado: (2011) -
Advanced Therapy Medicinal Products Challenges and Perspectives in Regenerative Medicine
por: Goula, Aspasia, et al.
Publicado: (2020) -
Implementation of Plasma Fractionation in Biological Medicines Production
por: Mousavi Hosseini, Kamran, et al.
Publicado: (2016)